Primary XXXX with Postoperative Adjuvant Radiotherapy: A Case Report.

@entity1 @entity41 @entity5 @entity602 @entity425 @entity158 @entity4097 @entity3271
Primary @entity602 are rare @entity5 comprising two percent of all @entity4097 . Although a treatment guideline has yet to be established, maximal surgical resection is primary in the treatment of @entity602 . Adjuvant radiotherapy has remained controversial, and it is unclear whether chemotherapy adds any benefit. In this case report, the authors present a 24-year-old male who had a seven-year history of @entity425 and a radiating @entity158 in both legs. Magnetic resonance image (MRI) showed an intramedullary mass at the T4-T8 level. He underwent subtotal @entity5 and pathologic diagnosis revealed a WHO grade II @entity3271 . The @entity1 was treated with radiotherapy postoperatively and followed up with MRI annually. Clinical and radiological status of the @entity1 had been stationary for four years after the surgery. The five-year follow-up MRI showed an increase in the size and extent of the @entity41 . Despite radiological progression, considering that symptoms and the performance status of the @entity1 had remained unchanged, further treatment has not been performed. Given the clinical outcome of this @entity1 , close observation after subtotal removal with adjuvant radiotherapy is one of the acceptable treatment options for WHO grade II @entity602 .
